Citadel Advisors
OPTN

Citadel Advisors’s OptiNose OPTN Stock Holding History

Citadel Advisors’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,603
Closed -$40.6K – 14944
2024
Q2 		$40.6K Sell
2,603
-4,295
-62% -$71.9K ﹤0.01% 11975
2024
Q1 		$151K Buy
6,898
+5,190
+304% +$115K ﹤0.01% 10754
2023
Q4 		$33.1K Buy
+1,708
New +$31.2K ﹤0.01% 12189
2023
Q2 		– Sell
-1,266
Closed -$36.7K – 14977
2023
Q1 		$36.7K Sell
1,266
-764
-38% -$20.3K ﹤0.01% 12534
2022
Q4 		$56.3K Buy
2,030
+1,140
+128% +$43.3K ﹤0.01% 11979
2022
Q3 		$49K Sell
890
-394
-31% -$21.6K ﹤0.01% 11648
2022
Q2 		$70K Sell
1,284
-451
-26% -$16.6K ﹤0.01% 11709
2022
Q1 		$64K Buy
+1,735
New +$61.9K ﹤0.01% 12636
2021
Q4 		– Sell
-1,189
Closed -$39.8K – 14467
2021
Q3 		$53K Buy
+1,189
New +$49.9K ﹤0.01% 13343
2020
Q3 		– Sell
-5,147
Closed -$574K – 10552
2020
Q2 		$574K Sell
5,147
-1,821
-26% -$130K ﹤0.01% 6829
2020
Q1 		$469K Sell
6,968
-1,059
-13% -$107K ﹤0.01% 6553
2019
Q4 		$1.11M Buy
8,027
+46
+0.6% +$5.97K ﹤0.01% 5407
2019
Q3 		$838K Buy
7,981
+4,500
+129% +$449K ﹤0.01% 5900
2019
Q2 		$370K Sell
3,481
-735
-17% -$96.8K ﹤0.01% 7267
2019
Q1 		$651K Sell
4,216
-296
-7% -$34.3K ﹤0.01% 6347
2018
Q4 		$420K Sell
4,512
-2,029
-31% -$290K ﹤0.01% 6680
2018
Q3 		$1.22M Buy
+6,541
New +$1.86M ﹤0.01% 5204

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors's OPTN Position: Q3 2024 in Review

Citadel Advisors sold out of OptiNose (OPTN) in Q3 2024, closing a stake of 2,603 shares — an estimated $40.6K sold.

Citadel Advisors first reported a position in OPTN in Q3 2018 and held it in 17 quarters. The position peaked at $1.22M in Q3 2018. 65 funds tracked by Wall St. Rank hold OPTN as of Q3 2024.

  • Citadel Advisors reported no remaining OptiNose position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 2,603 OptiNose shares in Q3 2024, an estimated $40.6K.
  • Citadel Advisors first reported a position in OptiNose in Q3 2018 and held it in 17 quarters.
  • Citadel Advisors's OptiNose position peaked at $1.22M in Q3 2018.
  • 65 funds tracked by Wall St. Rank held OptiNose as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.